ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

DCE Technical Support Contracts Recompetition Approved in Concept

November 22, 1991

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Study: Molecular Breast Imaging Can Be As Effective as MRI

July 27, 2012

Foundations: Biomedical Foundation Formed to Support NIH

September 27, 1996

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011